Subgroup analysis wasn’t accomplished regarding the association of KIR-HLA combinations and HLA-I ligands with different lung cancer subtypes owing to the inadequate sample size included in the HLA typing method. The gene discussed is KIR3DL1; the disease is lung carcinoma.